How many patents does
Respivert have?
patents
662
families
53
granted
159
applications
503
US
126
EP
64
WO
48
GB
39
CN
32
JP
31
KR
22
RoW
300
Buy the report
The report contains ten-year analysis with the following sections
- patent filing analysis
- worldwide filing analysis
- patent family analysis
- application analysis
- granted analysis
- classification analysis
- citation analysis
contact us for pricing
- VAT will apply to UK companies
- EU companies must supply their VAT number
Check out our sample pages |
Find companies to compare
Many companies now available
companies
12,000+
patents
42 million
patent families
23 million
Search to find companies of interest
read summary of their published patent
the following tables are just extracts from the report
the company report contains more information
Respivert
Top ten assignees appearing on patents
2009 - 2018
| respivert | 571 |
| topivert pharma | 144 |
| respivert limited and topivert pha… 🛈 | 1 |
| respivert limited [ | 1 |
2009
| respivert | 4 |
2018
| respivert | 49 |
| topivert pharma | 13 |
Respivert
The top ten patent families are
|
Title of patent family (most common patent title) |
Family members |
Filing year |
|---|---|---|
| compounds | 85 | 2009 |
| novel pharmaceutical formulations | 73 | 2012 |
| p38 map kinase inhibitors | 68 | 2008 |
| 1-pyrazolyl-3-(4-((2-anilinopyrimidin-4-yl)oxy)napththalen-1-yl)ureas as p38 map kinase … 🛈 | 52 | 2011 |
| aromatic heterocyclic compounds as antiinflammatory compounds | 39 | 2014 |
| kinase inhibitor | 37 | 2013 |
| 2-((4-amino-3-(3-fluoro-5-hydroxyphenyl)-1h-pyrazolo[3,4-d]pyrimidin-1 -yl)methyl)-3-(2-… 🛈 | 36 | 2013 |
| p38 map kinase inhibitors | 30 | 2008 |
| diaryl urea derivatives as p38 kinase inhibitors | 29 | 2014 |
| p38map kinase inhibitor | 23 | 2009 |